Select a medication above to begin.
Iluvien
fluocinolone intravitreal
Adult Dosing .
Dosage forms: IMPLANT: 0.19 mg
diabetic macular edema
- [1 implant intravitreally x1]
- Info: releases 0.25 mcg/day over 36mo
posterior uveitis, chronic non-infectious
- [1 implant intravitreally x1]
- Info: releases 0.25 mcg/day over 36mo
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.
Contraindications / Cautions .
- hypersensitivity to drug or ingredient
- glaucoma w/ cup-to-disc ratio >0.8
- ocular infection
- periocular infection
- caution: hypersensitivity to corticosteroids
- caution: HSV infection hx
- caution: posterior lens capsule, absent
- caution: posterior lens capsule, torn
Drug Interactions .
Overview
fluocinolone intravitreal
corticosteroid ophthalmic
- delays ocular healing
- immunosuppressive effects
Avoid/Use Alternative
- cladribine oral
- clobetasol ophthalmic
- dexamethasone ophthalmic
- difluprednate ophthalmic
- fluocinolone intravitreal
- fluorometholone ophthalmic
- hydrocortisone ophthalmic
- natalizumab
- pimecrolimus topical
- prednisolone ophthalmic
- triamcinolone intravitreal
- triamcinolone suprachoroidal
Monitor/Modify Tx
- carfilzomib
- temsirolimus
Caution Advised
- abatacept
- abemaciclib
- abrocitinib
- acalabrutinib
- adalimumab
- afamitresgene autoleucel
- aldesleukin
- alemtuzumab
- anakinra
- anifrolumab
- anti-thymocyte globulin
- atidarsagene autotemcel
- avacopan
- axicabtagene ciloleucel
- azacitidine
- azathioprine
- baricitinib
- basiliximab
- beclomethasone inhaled
- beclomethasone nasal
- belatacept
- belimumab
- belinostat
- bendamustine
- betamethasone
- bimekizumab
- blinatumomab
- bortezomib
- brentuximab vedotin
- brexucabtagene autoleucel
- brodalumab
- bromfenac ophthalmic
- budesonide
- budesonide inhaled
- budesonide nasal
- budesonide rectal
- busulfan
- cabazitaxel
- canakinumab
- carboplatin
- carmustine
- certolizumab pegol
- chlorambucil
- ciltacabtagene autoleucel
- cisplatin
- cladribine injection
- clofarabine
- copanlisib
- corticotropin
- cortisone
- crovalimab
- cyclophosphamide
- cyclosporine
- cytarabine
- dactinomycin
- danicopan
- daratumumab
- daunorubicin
- decitabine
- deflazacort
- deucravacitinib
- deuruxolitinib
- dexamethasone
- diclofenac ophthalmic
- dimethyl fumarate
- dinutuximab
- diroximel fumarate
- docetaxel
- doxorubicin
- dupilumab
- duvelisib
- eculizumab
- efgartigimod alfa
- elivaldogene autotemcel
- elotuzumab
- elranatamab
- emapalumab
- epcoritamab
- epirubicin
- eribulin
- etanercept
- etoposide
- etrasimod
- fingolimod
- floxuridine
- fludarabine
- fludrocortisone
- flunisolide nasal
- fluorouracil
- flurbiprofen ophthalmic
- fluticasone furoate
- fluticasone propionate
- fruquintinib
- gemcitabine
- gemtuzumab ozogamicin
- glofitamab
- golimumab
- guselkumab
- hydrocortisone
- hydroxyurea
- ibritumomab tiuxetan
- ibrutinib
- idarubicin
- idecabtagene vicleucel
- idelalisib
- ifosfamide
- inebilizumab
- infliximab
- inotuzumab ozogamicin
- iptacopan
- irinotecan
- isatuximab
- ixabepilone
- ixekizumab
- ketorolac ophthalmic
- lebrikizumab
- leflunomide
- lenalidomide
- lisocabtagene maraleucel
- lomustine
- loncastuximab tesirine
- lymphocyte immune globulin, anti-thymocyte globulin
- melphalan
- mercaptopurine
- methotrexate
- methylprednisolone
- mirikizumab
- mitoxantrone
- mogamulizumab
- momelotinib
- mometasone implant
- mometasone inhaled
- mometasone nasal
- monomethyl fumarate
- mosunetuzumab
- mycophenolate mofetil
- mycophenolic acid
- nelarabine
- nepafenac ophthalmic
- obecabtagene autoleucel
- obinutuzumab
- ocrelizumab
- ofatumumab
- omacetaxine mepesuccinate
- oxaliplatin
- ozanimod
- paclitaxel
- panobinostat
- pegcetacoplan
- pentostatin
- pirtobrutinib
- polatuzumab vedotin
- pomalidomide
- ponatinib
- ponesimod
- pozelimab
- pralatrexate
- prednisolone
- prednisone
- procarbazine
- quizartinib
- ravulizumab
- regorafenib
- rilonacept
- risankizumab
- ritlecitinib
- rituximab
- romidepsin
- ropeginterferon alfa-2b
- rozanolixizumab
- ruxolitinib
- ruxolitinib topical
- sarilumab
- satralizumab
- secukinumab
- selinexor
- siltuximab
- siponimod
- sirolimus
- sirolimus albumin-bound
- spesolimab
- sulfasalazine
- tacrolimus
- tafasitamab
- talquetamab
- tarlatamab
- teclistamab
- temozolomide
- teplizumab
- teriflunomide
- thioguanine
- thiotepa
- tildrakizumab
- tisagenlecleucel
- tocilizumab
- tofacitinib
- topotecan
- tralokinumab
- triamcinolone
- ublituximab
- upadacitinib
- ustekinumab
- vamorolone
- vedolizumab
- venetoclax
- vilobelimab
- vinblastine
- vincristine
- vinorelbine
- voclosporin
- zanubrutinib
- zilucoplan
Adverse Reactions .
Serious Reactions
- endophthalmitis
- secondary ocular infection
- glaucoma
- IOP incr.
- optic nerve damage
- visual acuity defect
- visual field defect
- cataracts
- ocular hypotony
- retinal detachment
- choroidal detachment
- delayed ocular wound healing
- globe perforation
- conjunctival hemorrhage
- vitreous hemorrhage
Common Reactions
- cataracts
- IOP incr.
- vitreous floaters
- visual acuity decr.
- ocular pain
- conjunctival hemorrhage
- posterior capsule opacification
- headache
- ocular irritation
- conjunctivitis
- corneal edema
- foreign body sensation
- ocular pruritus
- ocular hyperemia
- optic atrophy
- ocular discomfort
- ocular hypotony
- photophobia
- retinal exudates
- anterior chamber cells
- ocular discharge
- vitreous hemorrhage
Safety/Monitoring .
Monitoring Parameters
IOP
Look/Sound-Alike Drug Names
fluocinolone confused with: fludrocortisone; fluocinonide
Pregnancy/Lactation .
Pregnancy
Clinical Summary
may use during pregnancy; no human data available, though risk of fetal harm not expected based on insignificant systemic absorption
Lactation
Clinical Summary
may use while breastfeeding; no human data available, though risk of infant harm and adverse effects on milk production not expected based on insignificant maternal systemic absorption
Pharmacology .
Metabolism: liver; CYP450: unknown; Info: minimal systemic absorption
Excretion: urine; Half-life: 1.3-1.7h
Subclass: Corticosteroids, Ophthalmic
Mechanism of Action
exact mechanism of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple glucocorticoid and mineralocorticoid effects
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.